András Jánosi
András Jánosi
'Gottsegen' National Institute of Cardiology, Budapest, Hungary
Verified email at kardio.hu
TitleCited byYear
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
New England Journal of Medicine 345 (7), 494-502, 2001
73502001
Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in-congestive heart failure (MERIT-HF)
Merit-HF Study Group
The Lancet 353 (9169), 2001-2007, 1999
36721999
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre …
European Trial on Reduction of Cardiac Events with Perindopril in Stable ...
The Lancet 362 (9386), 782-788, 2003
25002003
Rosuvastatin in older patients with systolic heart failure
J Kjekshus, E Apetrei, V Barrios, M Böhm, JGF Cleland, JH Cornel, ...
New England Journal of Medicine 357 (22), 2248-2261, 2007
15762007
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial …
Å Hjalmarson, S Goldstein, B Fagerberg, H Wedel, F Waagstein, ...
Jama 283 (10), 1295-1302, 2000
15482000
Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries
DA Wood
The Lancet 357 (9261), 995-1001, 2001
8742001
EUROASPIRE: a European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results
EUROASPIRE Study Group
European Heart Journal 18 (10), 1569-1582, 1997
6311997
International application of a new probability algorithm for the diagnosis of coronary artery disease
R Detrano, A Janosi, W Steinbrunn, M Pfisterer, JJ Schmid, S Sandhu, ...
The American journal of cardiology 64 (5), 304-310, 1989
3301989
EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events …
KM Fox
Lancet 362, 782-788, 2003
313*2003
Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF)
A Hjalmarson, S Goldstein, B Fagerberg, H Wedel, F Waagstein, ...
Lancet 353 (9169), 2001-2007, 1999
1661999
Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of …
B Charbonnier, I Fotiadis, M Keltai, A Leizorovicz, M Marzilli, R Masia, ...
European Heart Journal 20 (21), 1553-1562, 1999
1641999
Factors affecting sensitivity and specificity of a diagnostic test: the exercise thallium scintigram
R Detrano, A Janosi, KP Lyons, G Marcondes, N Abbassi, VF Froelicher
The American journal of medicine 84 (4), 699-710, 1988
1441988
Body mass index, prognosis and mode of death in chronic heart failure: results from the Valsartan Heart Failure Trial
M Cicoira, AP Maggioni, R Latini, S Barlera, E Carretta, A Janosi, JS Soler, ...
European journal of heart failure 9 (4), 397-402, 2007
822007
Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF
A Jánosi, JK Ghali, J Herlitz, I Czuriga, M Klibaner, J Wikstrand, ...
American heart journal 146 (4), 721-728, 2003
712003
Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous …
AK Chakrabarti, K Feeney, C Abueg, DA Brown, E Czyz, M Tendera, ...
American heart journal 165 (4), 509-514. e7, 2013
702013
EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary …
CM Gibson, RP Giugliano, RA Kloner, C Bode, M Tendera, A Janosi, ...
European heart journal 37 (16), 1296-1303, 2015
682015
Cause of death and predictors of all‐cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF
SD Pokorney, JP Piccini, SR Stevens, MR Patel, KS Pieper, JL Halperin, ...
Journal of the American Heart Association 5 (3), e002197, 2016
602016
Usefulness of exercise-induced ST-segment depression in the inferior leads during exercise testing as a marker for coronary artery disease
CP Miranda, J Liu, A Kadar, A Janosi, J Froning, KG Lehmann, ...
American Journal of Cardiology 69 (4), 303-307, 1992
601992
Rationale, design, and organization of the metoprolol CR/XL randomized intervention trial in heart failure (MERIT-HF)
TISC on Behalf, MERIT-HF Study Group
The American Journal of Cardiology 80 (9), 54J-58J, 1997
481997
Exercise-induced ST depression and ST/heart rate index to predict triple-vessel or left main coronary disease: a multicenter analysis
M Bobbio, R Detrano, JJ Schmid, A Janosi, A Righetti, M Pfisterer, ...
Journal of the American College of Cardiology 19 (1), 11-18, 1992
351992
The system can't perform the operation now. Try again later.
Articles 1–20